AASLD guidelines for the treatment of hepatocellular carcinoma.

Hepatology (Baltimore, Md.) ·Vol. 67 ·No. 1 ·2018-00-00 ·Pages 358-380

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA

Abstract

暂无摘要

MeSH Terms

Carcinoma, Hepatocellular/therapy Humans Liver Neoplasms/therapy

Authors & Affiliations

9 authors, click to expand affiliations / ORCID

Heimbach Julie K

Division of Transplant Surgery, William J. von Liebig Transplant Center, Mayo Clinic, Rochester, MN.

Kulik Laura M

Department of Medicine, Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL.

Finn Richard S

Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica Geffen School of Medicine at UCLA, Los Angeles, California.

Sirlin Claude B

Liver Imaging Group, Department of Radiology, University of California, San Diego.

Abecassis Michael M

Northwestern University Feinberg School of Medicine, Chicago, IL.

Roberts Lewis R

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Zhu Andrew X

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.

Murad M Hassan

Mayo Clinic Evidence-based Practice Center, Mayo Clinic, Rochester, MN.

Marrero Jorge A

Digestive and Liver Diseases Division, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.

Article Info

Journal

Hepatology (Baltimore, Md.)

Abbr.

Hepatology

ISSN

1527-3350

DOI

10.1002/hep.29086

Published

2018-00-00

Pages

358-380

Language

English

Region

United States

NLM ID

8302946

Subset

External Links

PubMed source DOI: 10.1002/hep.29086 View journal details

Analysis Services

AASLD guidelines for the treatment of hepatocellular carcinoma.

Contact

WeChat Official Account